The emerging therapy of the medication represents a significant breakthrough in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – providing https://tirzepatidepeptide022096.vidublog.com/40657723/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment